Skip to content
A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer when mutated. The RAS is the most commonly mutated oncogene in […]
Startup Stadium: Tezcat Biosciences targets common cancer mutation Read More »
Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic
Psoriasis awareness: The condition is more than skin deep Read More »
M&A in biotech has slowed from its peak in 2023 but there are still deals to be done, especially for companies who can present
BIO 2025: As M&A slows, biotechs need to show good data Read More »
“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and
BIO 2025: How weight loss drugs are disrupting chronic disease Read More »
When experts discussed clinical uses of psychedelics two years ago at the 2023 Biotechnology Innovation Organization (BIO) International Convention, there was some interest in
BIO 2025: Psychedelics go mainstream – what’s next? Read More »
For most of her life, the only things coming out of left field for Kristin Smedley were fly balls, but with the birth of
Mother inspired to support solutions for her boys’ blindness Read More »
As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance
The federal government’s program that provides seed funding to support research by biotech startups provides much more than money, said program officials and small
BIO 2025: Federal seed funding also comes with valuable advice Read More »
Prostate cancer is the most common solid cancer among men, with 1 in 8 men being diagnosed in their lifetime and 1 in 44
Three questions men can ask about prostate cancer Read More »
As antimicrobial resistance (AMR) continues to threaten global public health, its impact on cancer patients is a growing, often overlooked crisis. Patients with cancer
BIO 2025: The urgent need to address AMR and cancer Read More »
